Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
Yuka Tanaka(Kyushu University), Takamichi Ito(Kyushu University)
Cited by 33
Related Papers
Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
|Journal of Dermatological Science|2015|120
Baicalein Inhibits Benzo[a]pyrene-Induced Toxic Response by Downregulating Src Phosphorylation and by Upregulating NRF2-HMOX1 System
|Antioxidants|2020|28
Systemic therapy for Asian patients with advanced <scp>BRAF V600</scp>‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (<scp>B‐CHECK‐RWD</scp> study)
|Cancer Medicine|2023|25
Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
|Journal of Clinical Medicine|2020|17
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
|Cell Death Discovery|2023|15